Dr. Tomer is the Anita and Jack Saltz Chair in Diabetes Research, Professor
and Chair of the Department of Medicine at Albert Einstein College of Medicine
and Montefiore Health System. Dr. Tomer received his MD degree from the Sackler
School of Medicine of Tel Aviv University, and trained in Internal Medicine at
Sheba Medical Center, Israel, and in Endocrinology at the Icahn School of
Medicine at Mount Sinai in New York. Dr.
Tomer’s research program focuses on the immunogenetic, epigenetic, and
environmental mechanisms underlying thyroid autoimmunity, and type 1 diabetes,
and on targeting these mechanisms in order to develop novel therapies. Among
his accomplishments are: discovery that CD40 is a major susceptibility gene for
autoimmune thyroid disease (AITD) and dissection of the mechanisms by which it
triggers AITD (a discovery that is the basis of a new therapeutic antibody that
was recently developed by pharma targeting CD40); identification of an HLA-DR
amino acid signature that is associated with both autoimmune diabetes and
thyroiditis; identification of new epigenetic mechanisms that trigger
autoimmune thyroiditis; and recently discovery of a compound that can block
antigen presentation and prevent autoimmune thyroiditis in mouse models. Dr.
Tomer published over 180 manuscripts and book chapters and he is frequently
invited nationally and internationally to give lectures about his research. Dr.
Tomer is a member of the American Society for Clinical Investigation and a
Fellow of the American College of Physicians. He is the recipient of several
awards including the American Thyroid Association Van Meter Award recognizing
his research accomplishments.
Attendance records:1
The lecture video:0
Abstract:1
486
0
0
第十六届国际甲状腺大会